Right Ventricular Function, Clinical Outcomes, and Effect of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: Secondary Analysis of the HELIOS-B Randomized Clinical Trial.
- DOI
- 10.1001/jamacardio.2026.3390
- Published
- 2026 Aug 26
- Container
- JAMA cardiology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1001/jamacardio.2026.3390,
title = {Right Ventricular Function, Clinical Outcomes, and Effect of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: Secondary Analysis of the HELIOS-B Randomized Clinical Trial.},
author = {Jering KS and Manafi A and Claggett BL and Fontana M and Gillmore JD and Bulwer BE and Roshanali F and Prasad N and Jay PY and Solomon SD and Skali H},
year = {2026},
journal = {JAMA cardiology},
doi = {10.1001/jamacardio.2026.3390},
url = {https://doi.org/10.1001/jamacardio.2026.3390}
}RIS
TY - JOUR TI - Right Ventricular Function, Clinical Outcomes, and Effect of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: Secondary Analysis of the HELIOS-B Randomized Clinical Trial. AU - Jering KS AU - Manafi A AU - Claggett BL AU - Fontana M AU - Gillmore JD AU - Bulwer BE AU - Roshanali F AU - Prasad N AU - Jay PY AU - Solomon SD AU - Skali H PY - 2026 JO - JAMA cardiology DO - 10.1001/jamacardio.2026.3390 UR - https://doi.org/10.1001/jamacardio.2026.3390 ER -
APA
KS, J., A, M., BL, C., M, F., JD, G., BE, B., F, R., N, P., PY, J., SD, S., & H, S. (2026). Right Ventricular Function, Clinical Outcomes, and Effect of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: Secondary Analysis of the HELIOS-B Randomized Clinical Trial.. JAMA cardiology. https://doi.org/10.1001/jamacardio.2026.3390
Source records
- pubmed · retrieved 2026-09-26T03:30:29.539Z
- europe-pmc · retrieved 2026-09-26T03:30:29.556Z